Gestational weight gain and adverse birth outcomes in South African women with HIV on antiretroviral therapy and without HIV: a prospective cohort study

IF 4.6 1区 医学 Q2 IMMUNOLOGY
Hlengiwe P. Madlala, Landon Myer, Jennifer Jao, Hayli Geffen, Mushi Matjila, Azetta Fisher, Demi Meyer, Erika F. Werner, Gregory Petro, Susan Cu-Uvin, Stephen T. McGarvey, Angela M. Bengtson
{"title":"Gestational weight gain and adverse birth outcomes in South African women with HIV on antiretroviral therapy and without HIV: a prospective cohort study","authors":"Hlengiwe P. Madlala,&nbsp;Landon Myer,&nbsp;Jennifer Jao,&nbsp;Hayli Geffen,&nbsp;Mushi Matjila,&nbsp;Azetta Fisher,&nbsp;Demi Meyer,&nbsp;Erika F. Werner,&nbsp;Gregory Petro,&nbsp;Susan Cu-Uvin,&nbsp;Stephen T. McGarvey,&nbsp;Angela M. Bengtson","doi":"10.1002/jia2.26313","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Introduction</h3>\n \n <p>Outside of pregnancy, evidence shows that persons with HIV initiating or switching to dolutegravir (DTG)-based antiretroviral therapy (ART) experience greater weight gain compared to those on other ART classes. However, there are few data on the impact of DTG-based ART on gestational weight gain (GWG) in sub-Saharan Africa where HIV is most common. According to the National Academy of Medicine (NAM), GWG below and above NAM guidelines is associated with adverse birth outcomes. Therefore, the objective of this study was to describe GWG by HIV status and ART regimen, and examine the associations with adverse birth outcomes.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>We enrolled pregnant women with HIV (WHIV) and without HIV (≥18 years) in a peri-urban primary healthcare facility in Cape Town, South Africa between 2019 and 2022. GWG was study-measured at 24–28 (baseline) and 33–38 weeks gestation and converted to GWG rate (kg/week) in accordance with NAM guidelines. GWG z-scores were generated using the INTEGROWTH-21 and US standards to account for differing lengths of gestation. Birth outcome data were obtained from medical records. Associations of GWG z-score with adverse birth outcomes were assessed using multivariable linear or log-binomial regression.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Among 292 participants (48% WHIV), median age was 29 years (IQR, 25–33), median pre-pregnancy body mass index (BMI) was 31 kg/m<sup>2</sup> (IQR, 26–36) and 20% were primiparous at baseline. The median weekly rate of GWG was 0.30 kg/week (IQR, 0.12–0.50), 35% had GWG below NAM standards (59% WHIV) and 48% had GWG above NAM standards (36% WHIV). WHIV gained weight more slowly (0.25 vs. 0.37 kg/week, <i>p</i>&lt;0.01) than women without HIV. Weekly rate of GWG did not differ by ART regimen (DTG-based ART 0.25 vs. efavirenz-based ART 0.27 kg/week, <i>p</i> = 0.80). In multivariable analyses, GWG z-score was positively associated with continuous birth weight (mean difference = 68.53 95% CI 8.96, 128.10) and categorical high birth weight of &gt;4000 g (RR = 2.18 95% CI 1.18, 4.01).</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Despite slower GWG among WHIV, nearly half of all women gained weight faster than recommended by the NAM. GWG was positively associated with infant birth weight. Interventions to support healthy GWG in sub-Saharan Africa are urgently needed.</p>\n </section>\n </div>","PeriodicalId":201,"journal":{"name":"Journal of the International AIDS Society","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11208166/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the International AIDS Society","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jia2.26313","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Outside of pregnancy, evidence shows that persons with HIV initiating or switching to dolutegravir (DTG)-based antiretroviral therapy (ART) experience greater weight gain compared to those on other ART classes. However, there are few data on the impact of DTG-based ART on gestational weight gain (GWG) in sub-Saharan Africa where HIV is most common. According to the National Academy of Medicine (NAM), GWG below and above NAM guidelines is associated with adverse birth outcomes. Therefore, the objective of this study was to describe GWG by HIV status and ART regimen, and examine the associations with adverse birth outcomes.

Methods

We enrolled pregnant women with HIV (WHIV) and without HIV (≥18 years) in a peri-urban primary healthcare facility in Cape Town, South Africa between 2019 and 2022. GWG was study-measured at 24–28 (baseline) and 33–38 weeks gestation and converted to GWG rate (kg/week) in accordance with NAM guidelines. GWG z-scores were generated using the INTEGROWTH-21 and US standards to account for differing lengths of gestation. Birth outcome data were obtained from medical records. Associations of GWG z-score with adverse birth outcomes were assessed using multivariable linear or log-binomial regression.

Results

Among 292 participants (48% WHIV), median age was 29 years (IQR, 25–33), median pre-pregnancy body mass index (BMI) was 31 kg/m2 (IQR, 26–36) and 20% were primiparous at baseline. The median weekly rate of GWG was 0.30 kg/week (IQR, 0.12–0.50), 35% had GWG below NAM standards (59% WHIV) and 48% had GWG above NAM standards (36% WHIV). WHIV gained weight more slowly (0.25 vs. 0.37 kg/week, p<0.01) than women without HIV. Weekly rate of GWG did not differ by ART regimen (DTG-based ART 0.25 vs. efavirenz-based ART 0.27 kg/week, p = 0.80). In multivariable analyses, GWG z-score was positively associated with continuous birth weight (mean difference = 68.53 95% CI 8.96, 128.10) and categorical high birth weight of >4000 g (RR = 2.18 95% CI 1.18, 4.01).

Conclusions

Despite slower GWG among WHIV, nearly half of all women gained weight faster than recommended by the NAM. GWG was positively associated with infant birth weight. Interventions to support healthy GWG in sub-Saharan Africa are urgently needed.

Abstract Image

南非接受抗逆转录病毒治疗和未接受抗逆转录病毒治疗的感染艾滋病毒妇女的妊娠体重增加与不良分娩结局:一项前瞻性队列研究。
导言:有证据表明,在妊娠期外,开始或转用基于多罗替拉韦(DTG)的抗逆转录病毒疗法(ART)的艾滋病病毒感染者与接受其他抗逆转录病毒疗法的艾滋病病毒感染者相比,体重增加幅度更大。然而,在 HIV 最常见的撒哈拉以南非洲地区,有关基于 DTG 的抗逆转录病毒疗法对妊娠体重增加 (GWG) 的影响的数据却很少。根据美国国家医学科学院(NAM)的研究,GWG 低于或高于 NAM 指南与不良出生结果有关。因此,本研究的目的是根据 HIV 感染状况和抗逆转录病毒疗法来描述 GWG,并研究其与不良分娩结局之间的关联:我们在 2019 年至 2022 年期间在南非开普敦的一个近郊初级医疗保健机构招募了感染 HIV 的孕妇(WHIV)和未感染 HIV 的孕妇(≥18 岁)。研究测量了妊娠 24-28 周(基线)和 33-38 周的 GWG,并根据 NAM 指南转换为 GWG 率(千克/周)。GWG z-分数根据 INTEGROWTH-21 和美国标准生成,以考虑不同的妊娠期。出生结果数据来自医疗记录。采用多变量线性回归或对数二项式回归评估 GWG z 分数与不良出生结局的关系:在 292 名参与者(48% WHIV)中,年龄中位数为 29 岁(IQR,25-33),孕前体重指数(BMI)中位数为 31 kg/m2(IQR,26-36),基线时 20% 为初产妇。每周体重增长速度的中位数为 0.30 千克/周(IQR,0.12-0.50),35% 的人的体重增长速度低于 NAM 标准(59% WHIV),48% 的人的体重增长速度高于 NAM 标准(36% WHIV)。WHIV 的体重增加速度更慢(0.25 vs. 0.37 kg/周,p4000 g (RR = 2.18 95% CI 1.18, 4.01)):尽管 WHIV 的 GWG 增重较慢,但仍有近一半的妇女的体重增长速度快于 NAM 建议的速度。GWG 与婴儿出生体重呈正相关。在撒哈拉以南非洲地区,迫切需要采取干预措施来支持健康的 GWG。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of the International AIDS Society
Journal of the International AIDS Society IMMUNOLOGY-INFECTIOUS DISEASES
CiteScore
8.60
自引率
10.00%
发文量
186
审稿时长
>12 weeks
期刊介绍: The Journal of the International AIDS Society (JIAS) is a peer-reviewed and Open Access journal for the generation and dissemination of evidence from a wide range of disciplines: basic and biomedical sciences; behavioural sciences; epidemiology; clinical sciences; health economics and health policy; operations research and implementation sciences; and social sciences and humanities. Submission of HIV research carried out in low- and middle-income countries is strongly encouraged.
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信